An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers

S. Agrawal, R. Awasthi, A. Singh, Mohammad Haris, R. K. Gupta, R. K S Rathore

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Aim: To assess the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) in prediction of the response to treatment in patients with head and neck cancers (HNCs). Methods and materials: Twenty-one patients with advanced HNC, suitable for concurrent chemoradiotherapy underwent DCE MRI, for the quantification of blood flow (BF) and volume (BV). All the patients received radical doses of conventionally fractionated radiotherapy up to a dose of 70 Gy along with concurrent weekly cisplatin. Results: The values of BV and BF were higher in complete responders as compared to partial responders at primary as well as nodes. Both BF and BV were found to be significantly higher in patients with high T-stage as compared to patients with lower T-stage. Conclusions: DCE metrics can be used as a predictor of response to treatment in locally advanced HNCs after validation of these observations in a larger number of patients.

Original languageEnglish
JournalClinical Radiology
Volume67
Issue number9
DOIs
Publication statusPublished - Sep 2012
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Blood Volume
Chemoradiotherapy
Cisplatin
Radiotherapy
Magnetic Resonance Imaging
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers. / Agrawal, S.; Awasthi, R.; Singh, A.; Haris, Mohammad; Gupta, R. K.; Rathore, R. K S.

In: Clinical Radiology, Vol. 67, No. 9, 09.2012.

Research output: Contribution to journalArticle

@article{9648c8095caf449b964bcedc200ed88c,
title = "An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers",
abstract = "Aim: To assess the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) in prediction of the response to treatment in patients with head and neck cancers (HNCs). Methods and materials: Twenty-one patients with advanced HNC, suitable for concurrent chemoradiotherapy underwent DCE MRI, for the quantification of blood flow (BF) and volume (BV). All the patients received radical doses of conventionally fractionated radiotherapy up to a dose of 70 Gy along with concurrent weekly cisplatin. Results: The values of BV and BF were higher in complete responders as compared to partial responders at primary as well as nodes. Both BF and BV were found to be significantly higher in patients with high T-stage as compared to patients with lower T-stage. Conclusions: DCE metrics can be used as a predictor of response to treatment in locally advanced HNCs after validation of these observations in a larger number of patients.",
author = "S. Agrawal and R. Awasthi and A. Singh and Mohammad Haris and Gupta, {R. K.} and Rathore, {R. K S}",
year = "2012",
month = "9",
doi = "10.1016/j.crad.2012.03.005",
language = "English",
volume = "67",
journal = "Clinical Radiology",
issn = "0009-9260",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers

AU - Agrawal, S.

AU - Awasthi, R.

AU - Singh, A.

AU - Haris, Mohammad

AU - Gupta, R. K.

AU - Rathore, R. K S

PY - 2012/9

Y1 - 2012/9

N2 - Aim: To assess the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) in prediction of the response to treatment in patients with head and neck cancers (HNCs). Methods and materials: Twenty-one patients with advanced HNC, suitable for concurrent chemoradiotherapy underwent DCE MRI, for the quantification of blood flow (BF) and volume (BV). All the patients received radical doses of conventionally fractionated radiotherapy up to a dose of 70 Gy along with concurrent weekly cisplatin. Results: The values of BV and BF were higher in complete responders as compared to partial responders at primary as well as nodes. Both BF and BV were found to be significantly higher in patients with high T-stage as compared to patients with lower T-stage. Conclusions: DCE metrics can be used as a predictor of response to treatment in locally advanced HNCs after validation of these observations in a larger number of patients.

AB - Aim: To assess the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) in prediction of the response to treatment in patients with head and neck cancers (HNCs). Methods and materials: Twenty-one patients with advanced HNC, suitable for concurrent chemoradiotherapy underwent DCE MRI, for the quantification of blood flow (BF) and volume (BV). All the patients received radical doses of conventionally fractionated radiotherapy up to a dose of 70 Gy along with concurrent weekly cisplatin. Results: The values of BV and BF were higher in complete responders as compared to partial responders at primary as well as nodes. Both BF and BV were found to be significantly higher in patients with high T-stage as compared to patients with lower T-stage. Conclusions: DCE metrics can be used as a predictor of response to treatment in locally advanced HNCs after validation of these observations in a larger number of patients.

UR - http://www.scopus.com/inward/record.url?scp=84864408408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864408408&partnerID=8YFLogxK

U2 - 10.1016/j.crad.2012.03.005

DO - 10.1016/j.crad.2012.03.005

M3 - Article

VL - 67

JO - Clinical Radiology

JF - Clinical Radiology

SN - 0009-9260

IS - 9

ER -